Podiatrist, Foot Surgery · Katy, TX
NPI
1033114822
Since 2005
Specialty
Podiatrist, Foot Surgery
Code 213ES0131X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
23230 Red River Dr
Katy, TX, 77494
Phone (281) 395-3338
Groups this clinician bills Medicare through
Medicare paid, 2024
$471K
7,623 services
Medicare patients, 2024
916
Average age 76
Drug cost, 2024
$81K
2,092 prescriptions
Company payments, 2025
$7,628
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Jacobs was code 87798 (infectious agent detection by dna/rna), 2,867 times for 223 patients. In total James M Jacobs billed 7,623 services in 84 codes, and Medicare paid $471K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87798 Infectious Agent Detection by DNA/RNA | Office | 2,867 | 223 | $34.32 | $98K |
| 99213 Office E&M - Established | Office | 884 | 525 | $62.43 | $55K |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 642 | 211 | $68.51 | $44K |
| 11721 Nail Procedure | Office | 401 | 247 | $28.88 | $12K |
| 11720 Nail Procedure | Office | 377 | 191 | $23.54 | $8,873 |
| 73630 X-ray - Lower Extremity | Office | 308 | 201 | $25.32 | $7,799 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 276 | 224 | $34.28 | $9,461 |
| 99203 Office E&M - New | Office | 251 | 251 | $68.98 | $17K |
| 93922 Duplex Scan - Extremity Arteries | Office | 211 | 209 | $63.65 | $13K |
| 11056 Removal or Shaving of Skin Growth | Office | 190 | 101 | $55.76 | $11K |
| 11055 Removal or Shaving of Skin Growth | Office | 106 | 79 | $45.49 | $4,822 |
| 93923 Duplex Scan - Extremity Arteries | Office | 90 | 90 | $77.78 | $7,000 |
| 99212 Office E&M - Established | Office | 85 | 74 | $42.53 | $3,615 |
| 99214 Office E&M - Established | Office | 64 | 57 | $86.66 | $5,546 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 63 | 42 | $0.76 | $47.61 |
By year: 2022 $438K for 6,549 services; 2023 $301K for 3,863 services; 2024 $471K for 7,623 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 2,867 | 223 | $34.32 | $98K |
| 87801 Infectious Agent Detection by DNA/RNA | 642 | 211 | $68.51 | $44K |
| 87481 Infectious Agent Detection by DNA/RNA | 276 | 224 | $34.28 | $9,461 |
| 87799 Infectious Agent Detection by DNA/RNA | 26 | 13 | $41.99 | $1,092 |
| 87641 Infectious Agent Detection by DNA/RNA | 13 | 13 | $34.39 | $447 |
| 87653 Infectious Agent Detection by DNA/RNA | 13 | 13 | $34.39 | $447 |
| 87640 Infectious Agent Detection by DNA/RNA | 13 | 13 | $34.39 | $447 |
| 87500 Infectious Agent Detection by DNA/RNA | 13 | 13 | $34.39 | $447 |
| 87651 Infectious Agent Detection by DNA/RNA | 12 | 12 | $34.39 | $413 |
Medicare prescription drug claims, 2024
In 2024, the drug James M Jacobs prescribed most often to Medicare patients was Meloxicam, with 322 prescriptions and refills. In total James M Jacobs wrote 2,092 Medicare prescriptions that cost $81K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meloxicam Generic | 322 | 342 | 159 | $1,081 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 319 | 339 | 214 | $12K |
| Clobetasol Propionate Generic | 282 | 286 | 212 | $16K |
| Ciclopirox Generic | 266 | 282 | 122 | $8,095 |
| Diclofenac Sodium Generic | 156 | 171 | 108 | $6,912 |
| Cephalexin Generic | 99 | 99 | 88 | $437 |
| Ketoconazole Generic | 75 | 75 | 41 | $1,728 |
| Gabapentin Generic | 72 | 94 | 28 | $493 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 57 | 59 | 40 | $1,308 |
| Tramadol Hcl Generic | 43 | 43 | 37 | $145 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 42 | 42 | 36 | $402 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 37 | 37 | 26 | $328 |
| Jublia Efinaconazole | 31 | 34 | Under 11 | $25K |
| Terbinafine Hcl Generic | 29 | 67 | 17 | $336 |
| Methylprednisolone Generic | 25 | 25 | 22 | $177 |
Brand drugs: 37 claims; generic drugs: 2,055 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Jacobs $7,628 ($1,778 in general payments such as food, travel and fees and $5,850 for research) from 14 companies. The largest payer was Tyber Medical, LLC with $5,850.
| Company | Payments | Amount |
|---|---|---|
| Tyber Medical, LLC | 1 | $5,850 |
| Fuse Medical, Inc. FZMD | 1 | $1,000 |
| Voom Medical Devices, Inc. | 2 | $203 |
| LifeNet Health | 1 | $154 |
| Stryker Corporation SYK | 1 | $140 |
| Smith+Nephew, Inc. SNN | 3 | $69.4 |
| Treace Medical Concepts, Inc. TMCI | 1 | $46.81 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $46.56 |
| Paratek Pharmaceuticals, Inc. | 2 | $31.54 |
| Boston Scientific Corporation BSX | 1 | $20.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.